Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05391932 · ClinicalTrials.gov registry record · NA
Making INformed Decisions in Gaze and Postural Stability: A Pilot Feasibility Study
A NA study of Vestibular Hypofunction, sponsored by University of Montana.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05391932: Recruiting NA study of Vestibular Hypofunction, sponsored by University of Montana.
NCT05391932 is a NA study of Vestibular Hypofunction that is actively recruiting participants, run by University of Montana. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05391932, a NA study of Vestibular Hypofunction, is actively recruiting participants, sponsored by University of Montana.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research is relevant to vestibular science and the general public because age-related vestibular hypofunction is a major contributor to poor balance, falls, and other adverse health outcomes. In this investigation the investigators will: 1) assess the preliminary efficacy of a novel intervention system for improving vestibular function and dizziness in community-dwelling older adults, 2) assess the safety and feasibility of the this system, and 3) assess the acceptability and implementation potential of this system, prior to a large-scale, R01-level investigation.
Primary Outcome
computerized measure of functional gaze stability
Conditions Studied
Interventions
- BEHAVIORAL MINDGAPS
Study Locations (1)
Montana
- University of Montana - Missoula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-05-11 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What NCT05391932 shows while recruiting
NCT05391932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Vestibular Hypofunction appearing as the primary indexed condition, and to 1 intervention - of which MINDGAPS is the first listed.
NCT05391932 reports a single indexed study location in Montana.
Frequently Asked Questions
What is clinical trial NCT05391932 about?
NCT05391932 is a clinical study titled "Making INformed Decisions in Gaze and Postural Stability: A Pilot Feasibility Study". The proposed research is relevant to vestibular science and the general public because age-related vestibular hypofunction is a major contributor to poor balance, falls, and other adverse health outcomes. In this investigation the investigators will: 1) assess the preliminary efficacy of a novel int...
What is the current status of trial NCT05391932?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2022-05-11. Estimated completion is 2025-03-31.
What conditions does trial NCT05391932 study?
This clinical trial studies the following conditions: Vestibular Hypofunction.
What interventions are being tested in trial NCT05391932?
The interventions under investigation include: MINDGAPS (BEHAVIORAL).
Who is sponsoring clinical trial NCT05391932?
This trial is sponsored by University of Montana, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05391932 being conducted?
This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vestibular Hypofunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05391932's enrollment target sits among peer trials
36 1542nd of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI